Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 2/20 | 0.34 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tributylmethylammonium SCHEMBL306587 | 0.86 | RECQL (0.41) | POLBRECQLBBOX1GLAHPGD | |
| SCHEMBL17237452 | 0.86 | POLB (0.46) | POLBRECQLBBOX1GLAHPGD | |
| Sulfuric Acid SCHEMBL8397794 | 0.85 | BBOX1 (0.39) | RECQLBBOX1GLAHPGDTSHR | |
| SCHEMBL11291479 | 0.85 | RECQL (0.44) | RECQLGLAHPGDTSHRMAPK1 | |
| Tetrapropylammonium SCHEMBL5570492 | 0.83 | SLC22A1 (0.50) | POLBRECQLBBOX1GLAHPGD | |
| Sulfuric Acid Dimethyl Ester SCHEMBL27687755 | 0.83 | SLC22A1 (0.30) | TSHR | |
| SCHEMBL11290328 | 0.83 | RECQL (0.47) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL2995385 | 0.83 | RECQL (0.47) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL4665831 | 0.83 | RECQL (0.47) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL10588897 | 0.83 | RECQL (0.47) | RECQLGLAHPGDTSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1362022-B1 | METHOD FOR PRODUCING ORTHOCARBONIC ACID TRIALKYL ESTERS | BASF AG (DE) | 2007-11-28 | — | — | EP | claimed |
| US-7192512-B2 | Method for producing orthocarbonic acid trialkyl esters | BASF AKTIENGESELLSCHAFT (DE) | 2007-03-20 | — | — | US | claimed |
| US-20030183534-A1 | Method for producing orthocarbonic acid trialkyl esters | BASF AKTIENGESELLSCHAFT (DE) | 2003-10-02 | — | — | US | claimed |
| US-7863486-B2 | Electrochemical preparation of sterically hindered amines | BASF SE (DE) | 2011-01-04 | — | — | US | disclosed |
| EP-2041336-B1 | ELECTROCHEMICAL PRODUCTION OF STERICALLY HINDERED AMINES | BASF SE (DE) | 2010-12-29 | — | — | EP | disclosed |
| US-20090253937-A1 | ELECTROCHEMICAL PRODUCTION OF STERICALLY HINDERED AMINES | BASF SE (DE) | 2009-10-08 | — | — | US | disclosed |
| EP-2041336-A2 | ELECTROCHEMICAL PRODUCTION OF STERICALLY HINDERED AMINES | BASF SE (DE) | 2009-04-01 | — | — | EP | disclosed |
| CN-101137635-A | Method for producing alkoxylated 2,5-dihydrofuran but-2-ene derivatives or tetra-1,1,4,4-alkoxylated but-2-ene derivatives | BASF AG (DE) | 2008-03-05 | — | — | CN | disclosed |
| WO-2008003620-A2 | ELECTROCHEMICAL PRODUCTION OF STERICALLY HINDERED AMINES | BASF SE (DE) | 2008-01-10 | — | — | WO | disclosed |
| US-4288300-A | IN ELECTROLYTIC CELL HAVING ALKALI METAL OR TETRAALKYLAMMONIUM ALKOSULFATE AS ELECTROLYTE | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-09-08 | — | — | US | disclosed |
| EP-0019226-A1 | Process for preparing N-(alpha-alkoxyethyl)-carboxylic acid amides | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-11-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253937-A1 | ELECTROCHEMICAL PRODUCTION OF STERICALLY HINDERED AMINES | AOC2, CYCS, SCO2 | POLB 571/4885RECQL 2277/4885BBOX1 486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.